References

HCP SITE

Welcome Page

1. Consilient Health Ltd, Altavita D3 1,000 IU soft capsules, Summary of product characteristics – available on medicines.ie

2. Consilient Health Ltd, Altavita D3 7,000 IU soft capsules, Summary of product characteristics – available on  medicines.ie

3. Consilient Health Ltd, Altavita D3 25,000 IU soft capsules, Summary of product characteristics – available on medicines.ie

4. Consilient Health Ltd, Altavita D3 25,000 IU oral solution, Summary of product characteristics – available on  medicines.ie

Role of Vitamin D and Vitamin D Deficiency Page

1. Cashman K et al. Vitamin D status of Irish adults: findings from the National Adult Nutrition Survey. British Journal of Nutrition (2013), 109, 1248-1256.

2. Haroon M and Regan M. Vitamin D deficiency: the time to ignore it has passed. International Journal of Rheumatic Diseases 2010; 13: 318-323.

3. Lips et al. The effect of vitamin D on bone and osteoporosis. Best Practice & Research Clinical Endocrinology & Metabolism 25, (2011), 585-591.

4.  National Osteoporosis Society (NOS). Vitamin D and Bone Health: A Practical Clinical Guideline for Patient Management. December 2018. V2.

5. Holick M et al. Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab; July 2011; 96(7): 1911-30.

6. Recommendations Abstracted from the American Geriatrics Society Consensus Statement on Vitamin D for Prevention of Falls and Their Consequences. J Am Geriatr Soc 62: 147-152, 2014.

7. Hanley D et al. Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada (summary). CMAJ 2010, Sep 7; 182(12): 1315-1319.

8. Wagner C et al. Prevention of Rickets and Vitamin D Deficiency in Infants, Children, and Adolescents. Paediatrics Vol 122: No. 5 November 1, 2008, 1142-1152.

9. Godel J et al. Recommendations for Canadian mothers and infants. Paediatr Child Health 2007; 12(7): 583-9.

10. Tangpricha V et al. . An Update on the Screening, Diagnosis, Management and Treatment of Vitamin D Deficiency in Individuals with Cystic Fibrosis: Evidence-Based Recommendations from the Cystic Fibrosis Foundation. J Clin Endocrinol Metab April 2012, 97(4): 1082-1093.

11. http://blogs.longwood.edu/osteomalacia/2012/07/06/what-is-osteomalacia/ accessed 24/10/17

Prevalence of Vitamin D Deficiency page

1. Cashman K et al. Vitamin D status of Irish adults: findings from the National Adult Nutrition Survey. British Journal of Nutrition (2013), 109, 1248-1256.

International Guidelines and Recommendations page

1. https://www.fsai.ie/faq/vitamin_d.html accessed 24th October 2017

2.  National Osteoporosis Society (NOS). Vitamin D and Bone Health: A Practical Clinical Guideline for Patient Management. December 2018. V2.

3. Holick M et al. Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab; July 2011; 96(7): 1911-30.

4. Recommendations Abstracted from the American Geriatrics Society Consensus Statement on Vitamin D for Prevention of Falls and Their Consequences. J Am Geriatr Soc 62: 147-152, 2014.

5. Hanley D et al. Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada (summary). CMAJ 2010, Sep 7; 182(12): 1315-1319.

6. Wagner C et al. Prevention of Rickets and Vitamin D Deficiency in Infants, Children, and Adolescents. Paediatrics Vol 122: No. 5 November 1, 2008, 1142-1152.

7. Godel J et al. Recommendations for Canadian mothers and infants. Paediatr Child Health 2007; 12(7): 583-9.

8. Tangpricha V et al. . An Update on the Screening, Diagnosis, Management and Treatment of Vitamin D Deficiency in Individuals with Cystic Fibrosis: Evidence-Based Recommendations from the Cystic Fibrosis Foundation. J Clin Endocrinol Metab April 2012, 97(4): 1082-1093. Vitamin D:

Vitamin D3: The Evidence in Adults page

1. Chapuy MC et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. NEJM 1992; 327(23):1637-42.

2. Dawson-Hughes B et al. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. NEJM 1997; 337 (10):670-6.

3. Hitz MF et al. Bone mineral density and bone markers in patients with a recent low-energy fracture: effect of 1 year of treatment with calcium and vitamin D. Am J Clin Nutr 2007; 86(1):251-9.

4. Bischoff-Ferrari H et al. Prevention of Nonvertebral Fractures With Oral Vitamin D and Dose Dependency. Arch Intern Med. Vol 169 (No. 6) March 23, 2009.

Vitamin D3: The Evidence in Children and Adolescents page

1. McNally JD, Kusum M, Chakraborty P, et al. The association of vitamin D status with pediatric critical illness. Pediatrics. 2012;130(3):429–436.

2. Madden K, Feldman HA, Smith EM, et al. Vitamin D deficiency in critically ill children. Pediatrics. 2012 Sep;130(3):421-8.

3. Whiting SJ, Langlois KA, Vatanparast H, Greene-Finestone LS. The vitamin D status of Canadians relative to the 2011 Dietary Reference Intakes: an examination in children and adults with and without supplement use. Am J Clin Nutr 2011; 94(1):128-35.

4. Absoud M, Cummins C, Lim MJ, Wassmer E, Shaw N. Prevalence and predictors of vitamin D insufficiency in children: a Great Britain population based study. PLoS One 2011; 6(7):e22179.

5. Ward KA, Das G, Berry JL et al. Vitamin D status and muscle function in post-menarchal adolescent girls. J Clin Endocrinol Metab 2009; 94(2):559-6.

6. Cashman KD, Hill TR, Cotter AA et al. Low vitamin D status adversely affects bone health parameters in adolescents. Am J Clin Nutr 2008; 87(4):1039-44.

7. Sayers A, Fraser WD, Lawlor DA, Tobias JH. 25-Hydroxyvitamin-D3 levels are positively related to subsequent cortical bone development in childhood: findings from a large prospective cohort study. Osteporos Int 2012; 23(8):2117-28.

Are Vitamin D3 and Vitamin D2 equivalent?

1. Houghton L, Vieth, R. The case against ergocalciferol (vitamin D2) as a vitamin supplement. Am J Clin Nutr October 2006, vol 84, no. 4, 694-697.

2. Tjellesen L, Hummer L, Christiansen C, Rødbro P. Serum concentration of vitamin D metabolites during treatment with vitamin D2 and D3 in normal premenopausal women. Bone Miner. 1986:1:407-413.

3. Trang HM, Cole DE, Rubin LA, Pierratos A, Siu S, Vieth R. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr. 1998; 68: 854-858.

4. Bischoff-Ferrari H et al. Prevention of Nonvertebral Fractures With Oral Vitamin D and Dose Dependency. Arch Intern Med. Vol 169 (No. 6) March 23, 2009.

5. National Osteoporosis Society. Vitamin D and Bone Health: A Practical Clinical Guideline for Patient Management. April 2013. V1.1.

About Altavita D3 page

1. Consilient Health Ltd, Altavita D3 1,000 IU soft capsules, Summary of product characteristics – available on  medicines.ie

2. Consilient Health Ltd, Altavita D3 7,000 IU soft capsules, Summary of product characteristics – available on  medicines.ie

3. Consilient Health Ltd, Altavita D3 25,000 IU soft capsules, Summary of product characteristics – available on  medicines.ie

4. Consilient Health Ltd, Altavita D3 25,000 IU oral solution, Summary of product characteristics – available on  medicines.ie

5. Ish-Shalom S et al. Comparison of daily, weekly, and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients. J Clin Endocrinol Metab 2008; 93(9): 3430-3435.

How to take Altavita D3

1. Consilient Health Ltd, Altavita D3 1,000 IU soft capsules, Summary of product characteristics – available on  medicines.ie

2. Consilient Health Ltd, Altavita D3 7,000 IU soft capsules, Summary of product characteristics – available on  medicines.ie

3. Consilient Health Ltd, Altavita D3 25,000 IU soft capsules, Summary of product characteristics – available on  medicines.ie

4. Consilient Health Ltd, Altavita D3 25,000 IU oral solution, Summary of product characteristics – available on  medicines.ie

Altavita D3 Safety Profile

1. Consilient Health Ltd, Altavita D3 1,000 IU soft capsules, Summary of product characteristics – available on  medicines.ie

2. Consilient Health Ltd, Altavita D3 7,000 IU soft capsules, Summary of product characteristics – available on medicines.ie

3. Consilient Health Ltd, Altavita D3 25,000 IU soft capsules, Summary of product characteristics – available on  medicines.ie

4. Consilient Health Ltd, Altavita D3 25,000 IU oral solution, Summary of product characteristics – available on  medicines.ie

Altavita D3 Prescribing Information

1. Consilient Health Ltd, Altavita D3 1,000 IU soft capsules, Summary of product characteristics – available on  medicines.ie

2. Consilient Health Ltd, Altavita D3 7,000 IU soft capsules, Summary of product characteristics – available on  medicines.ie

3. Consilient Health Ltd, Altavita D3 25,000 IU soft capsules, Summary of product characteristics – available on  medicines.ie

4. Consilient Health Ltd, Altavita D3 25,000 IU oral solution, Summary of product characteristics – available on  medicines.ie

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close